Several proposals to lower drug costs have been introduced in recent years in response to growing public concern about drug prices and affordability. A key element included in recent proposals would tie the prices of certain medicines to the prices paid in other countries. As discussions on these policies continue, it is important to consider how these proposals may affect research and development decisions and capital investments in the sector. In this session, experts will discuss how policymakers can address patients' concerns about drug prices while sustaining robust investment in drug development.